Medicure (OTCMKTS:MCUJF) Announces Earnings Results

Medicure (OTCMKTS:MCUJF) announced its quarterly earnings data on Thursday. The company reported ($0.03) EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.01, Zacks reports. The company had revenue of $5.79 million during the quarter, compared to the consensus estimate of $3.63 million. Medicure had a negative net margin of 21.65% and a negative return on equity of 42.01%.

Medicure Price Performance

Shares of Medicure stock opened at $0.80 on Friday. The company has a market cap of $8.39 million, a P/E ratio of -1.71 and a beta of 0.97. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.77 and a current ratio of 1.02. Medicure has a one year low of $0.68 and a one year high of $0.97. The firm has a fifty day moving average of $0.83 and a two-hundred day moving average of $0.84.

Medicure Company Profile

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.